Acuta Capital Partners, LLC Portfolio Holdings

Acuta Capital Partners, LLC

  • $52.7 Million
  • Q1 2025

Acuta Capital Partners, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $52.7 Million distributed in 34 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $8.94M, Insmed Inc with a value of $8.09M, Aadi Bioscience, Inc. with a value of $6.07M, Trevi Therapeutics, Inc. with a value of $4.94M, and Argenx Se with a value of $4.16M.

Examining the 13F form we can see an decrease of $17.6M in the current position value, from $70.3M to 52.7M.

Acuta Capital Partners, LLC is based out at Belmont, CA

Below you can find more details about Acuta Capital Partners, LLC portfolio as well as his latest detailed transactions.

Portfolio value $52.7 Million
Healthcare: $52.7 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$770M
$8.94 Million 16.96% of portfolio
1,219,724
Q1 2025 Added 9.78%
$13.8B
$8.09 Million 15.35% of portfolio
106,074
Q1 2025 Added 1.22%
$35.9M
$6.07 Million 11.51% of portfolio
3,410,402
Q1 2025 Added 84.41%
$343M
$4.94 Million 9.38% of portfolio
785,961
Q1 2025 Added 1.81%
$31.1B
$4.16 Million 7.88% of portfolio
7,023
Q1 2025 Added 1.64%
$9.76B
$3.64 Million 6.9% of portfolio
23,340
Q1 2025 Added 1.58%
$3.36B
$2.36 Million 4.47% of portfolio
66,662
Q1 2025 Reduced 40.32%
$801M
$2.26 Million 4.29% of portfolio
153,482
Q1 2025 Added 11.45%
$212B
$2.06 Million 3.91% of portfolio
22,994
Q1 2025 New
$797M
$1.88 Million 3.56% of portfolio
85,454
Q1 2025 Reduced 2.51%
$357M
$1.78 Million 3.38% of portfolio
791,815
Q1 2025 Added 1.6%
$74.8M
$1.34 Million 2.54% of portfolio
2,352,887
Q1 2025 Added 2.17%
$6.99B
$1.19 Million 2.25% of portfolio
9,575
Q1 2025 New
$140B
$1.04 Million 1.97% of portfolio
9,298
Q1 2025 Added 1.62%
$167M
$898,000 1.7% of portfolio
325,550
Q1 2025 Reduced 27.25%
$2.05B
$770,000 1.46% of portfolio
21,290
Q1 2025 Added 1.38%
$231M
$555,000 1.05% of portfolio
83,350
Q1 2025 Reduced 38.03%
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 21.33%
Verastem Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Surrozen Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 3.31%
Rapport Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 6.82%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 0.79%
Forte Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 1.82%
Helix Acquisition Corp Ii
-
$0 0.0% of portfolio
-
Q1 2025 Added 3.49%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 130.77%
-
$0 0.0% of portfolio
-
Q2 2022 New
Bright Minds Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 13.56%
Oculis Holding Ag
-
$0 0.0% of portfolio
-
Q1 2025 New
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q1 2025 Added 29.1%
Zymeworks Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 1.81%

Summary

  • Portfolio
  • No. of Stocks 34
  • Current Value $52.7 Million
  • Prior Value $70.3 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 7 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email